Hansa Biopharma to host conference call to provide Year-end 2022 results and a Business Update
Lund, Sweden, January 20, 2023 Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its Year-end Report 2022 at 8:00 CET on February 2, 2023. All interested parties are invited to participate in a telephone conference, which will include a presentation of the year-end results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events &